The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Febuxostat Rowa 80 mg film-coated tablets



Rowa Pharmaceuticals LimitedPA0074/085/001

Main Information

Trade NameFebuxostat Rowa 80 mg film-coated tablets
Active SubstancesFebuxostat
Dosage FormFilm-coated tablet
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/085/001

Group Information

ATC CodeM04AA Preparations inhibiting uric acid production
M04AA03 febuxostat

Status

License statusAuthorised
Licence Issued30/04/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back